Ablation of Sphingosine Kinase 2 Suppresses Fatty Liver-Associated Hepatocellular Carcinoma via Downregulation of Ceramide Transfer Protein

Scientists reported that sphingosine kinase 2, a key sphingolipid metabolic enzyme, played a critical role in non-alcoholic fatty liver disease-associated HCC.